| Amy Renee Martz, CRNA | |
|
15000 Midlantic Dr, Suite 102, Mount Laurel, NJ 08054-1573 | |
| (856) 829-9345 | |
| Not Available |
| Full Name | Amy Renee Martz |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 15000 Midlantic Dr, Mount Laurel, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780120519 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR18553600 (New Jersey) | Primary |
| 163W00000X | Registered Nurse | RN658164 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Stratford Hospital | Stratford, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rancocas Anesthesiology Pa | 2769380237 | 88 |
News Archive
Joint inflammation (arthritis) is a common problem in medical practice and can be due to a variety of causes. Many types of inflammatory disorders affecting the joints belong to the diverse group of rheumatic diseases.
Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.
Researchers have found that prescribed low doses of steroids, often to combat inflammatory diseases, are at an increased risk of cardiovascular diseases.
A study in Norway has recently highlighted a significant association between gut microbiota alteration and persistent respiratory dysfunction in coronavirus disease 2019 (COVID-19) patients.
› Verified 5 days ago
| Entity Name | Rancocas Anesthesiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427076553 PECOS PAC ID: 2769380237 Enrollment ID: O20031222000327 |
News Archive
Joint inflammation (arthritis) is a common problem in medical practice and can be due to a variety of causes. Many types of inflammatory disorders affecting the joints belong to the diverse group of rheumatic diseases.
Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.
Researchers have found that prescribed low doses of steroids, often to combat inflammatory diseases, are at an increased risk of cardiovascular diseases.
A study in Norway has recently highlighted a significant association between gut microbiota alteration and persistent respiratory dysfunction in coronavirus disease 2019 (COVID-19) patients.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Renee Martz, CRNA 327 E Allen St, Apt 1, Philadelphia, PA 19125-4237 Ph: () - | Amy Renee Martz, CRNA 15000 Midlantic Dr, Suite 102, Mount Laurel, NJ 08054-1573 Ph: (856) 829-9345 |
News Archive
Joint inflammation (arthritis) is a common problem in medical practice and can be due to a variety of causes. Many types of inflammatory disorders affecting the joints belong to the diverse group of rheumatic diseases.
Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain.
Researchers have found that prescribed low doses of steroids, often to combat inflammatory diseases, are at an increased risk of cardiovascular diseases.
A study in Norway has recently highlighted a significant association between gut microbiota alteration and persistent respiratory dysfunction in coronavirus disease 2019 (COVID-19) patients.
› Verified 5 days ago
Brittany Killian, APRN Registered Nurse Medicare: Medicare Enrolled Practice Location: 1120 Route 73 Ste 300, Mount Laurel, NJ 08054 Phone: 856-288-9612 | |
Linda Lazar, MSN RN CS Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 22 Shadow Oak Court, Mount Laurel, NJ 08054 Phone: 856-866-0614 Fax: 856-231-9235 | |
Anushree Ghosh, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 107a Hastings Way, Mount Laurel, NJ 08054 Phone: 800-950-6066 | |
Amanda Magen, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1080 Union Mill Rd, Mount Laurel, NJ 08054 Phone: 856-816-7026 | |
Ms. Carol Liimakka, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 130 Gaither Dr, Mount Laurel, NJ 08054 Phone: 856-722-7000 Fax: 856-829-0580 | |
Ms. Michelle Rufino, CRNA Registered Nurse Medicare: Medicare Enrolled Practice Location: 130 Gaither Dr, Mount Laurel, NJ 08054 Phone: 856-772-7000 Fax: 856-829-0580 | |
Stephanie Downes, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 233a Derry Hill Ct, Mount Laurel, NJ 08054 Phone: 856-380-0741 |